NCT00238199 Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00234416 IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00233415 Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00225784 Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00209677 Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status SUSPENDED Phase PHASE1/PHASE2
NCT00202800 Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00197431 Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer Status UNKNOWN Phase PHASE2
NCT00192712 Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00185588 Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00183846 Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers Status COMPLETED Phase PHASE1
NCT00179751 A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas Status TERMINATED Phase PHASE1/PHASE2
NCT00177853 Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00176813 Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00176735 Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer Status TERMINATED Phase NA
NCT00161213 Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00159471 Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. Status TERMINATED Phase NA
NCT00149578 A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT00128622 Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer Status COMPLETED Phase PHASE1